This document provides guidance on proficiency testing (PT) and outlines a number of challenges in PT, as well as potential approaches government agencies, regulatory bodies, and PT providers can take to address challenges. The full best practice recommendations are available here.

This document aggregates insight from CANNRA members to identify minimum requirements and best practices in cannabinoid regulation to protect consumer safety and public health. The full document is available here.

This factsheet is publicly available and provides a brief one-page factual overview of hemp and hemp-derived cannabinoid products that can help inform policymakers, regulators, and community organizations. The factsheet is available here.

This factsheet is publicly available and provides a longer version of the brief factual overview of hemp and hemp-derived cannabinoid products that can help inform policymakers, regulators, and community organizations. The full factsheet is available here.

This factsheet is publicly available and provides a brief 1-page overview of the regulatory challenges related to hemp-derived cannabinoid products. This factsheet is intended as an educational resource and is not a formal policy position of CANNRA. The factsheet is available here.

This factsheet is publicly available and provides a longer overview of the regulatory challenges related to hemp-derived cannabinoid products. This factsheet is intended as an educational resource and is not a formal policy position of CANNRA. The full factsheet is available here.

This guidance document, which is only available to CANNRA members, provides insights to help state and local environmental regulatory agencies to apply existing environmental regulations to the emerging cannabis industry to promote environmental compliance.

This guidance document, which is only available to CANNRA members, provides insights to help state and local regulatory agencies apply existing odor regulations to the cannabis industry, and to understand the science behind cannabis odors, which can cause complaints from the public.

This guidance document, which is only available to CANNRA members, provides insights on the lessons learned and best practices to develop and improve medical cannabis programs in ways that support patients, clinicians, and access to safe medical cannabis products.